4//SEC Filing
CATALYST PHARMACEUTICAL PARTNERS, INC. 4
Accession 0001161697-14-000496
$CPRXCIK 0001369568operating
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:29 PM ET
Size
8.6 KB
Accession
0001161697-14-000496
Insider Transaction Report
Form 4
HUCKEL HUBERT E MD
Director10% Owner
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2014-10-02$0.90/sh+30,000$27,000→ 1,334,134 total - Exercise/Conversion
Options to purchase common stock
2014-10-02−30,000→ 639,804 totalExercise: $0.90From: 2009-10-20Exp: 2014-10-20→ Common Stock (30,000 underlying) - Tax Payment
Common stock, par value $0.001 per share
2014-10-02−9,964→ 1,324,170 total
Footnotes (1)
- [F1]Holder exercised 30,000 options at $0.90 per share via cashless exercise and was issued 20,036 shares based on the October 2, 2014 closing price of $2.71 per share.
Documents
Issuer
CATALYST PHARMACEUTICAL PARTNERS, INC.
CIK 0001369568
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369568
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:29 PM ET
- Size
- 8.6 KB